PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-11.03%
Both yoy net incomes decline, with MRVL at -6.87%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
1.59%
Some D&A expansion while MRVL is negative at -1.04%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
90.54%
Deferred tax of 90.54% while MRVL is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
No Data
No Data available this quarter, please select a different quarter.
-49.01%
Both reduce yoy usage, with MRVL at -1299.50%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-100.00%
AR is negative yoy while MRVL is 0.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
54.37%
Some inventory rise while MRVL is negative at -230.38%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
100.00%
AP growth of 100.00% while MRVL is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might matter for short-term liquidity if expansions are large.
-10033.33%
Negative yoy usage while MRVL is 3.03%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
400.00%
Some yoy increase while MRVL is negative at -145.07%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-19.03%
Both yoy CFO lines are negative, with MRVL at -219.91%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-23.29%
Negative yoy CapEx while MRVL is 40.41%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
99.18%
Purchases well above MRVL's 94.72%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
-88.60%
We reduce yoy sales while MRVL is 423.86%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
No Data
No Data available this quarter, please select a different quarter.
-146.29%
We reduce yoy invests while MRVL stands at 102.46%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
17.11%
Issuance growth of 17.11% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
50.46%
Buyback growth of 50.46% while MRVL is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.